Roy S. Herbst

Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base.

R. Herbst, L. Gaspar, J. Crawford, 2005, Clinical lung cancer.

Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.

C. Bucana, R. Herbst, J. Wood, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Role of novel targeted therapies in the clinic

R. Herbst, Roy S. Herbst, 2005, British Journal of Cancer.

Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

C. Bucana, F. Khuri, W. Hong, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer.

F. Khuri, W. Hong, R. Herbst, 2001, Lung cancer.

Small-cell lung cancer: prognostic factors and changing treatment over 15 years.

R. Herbst, L. Gaspar, J. Crawford, 2012, Clinical lung cancer.